These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 9177196)
1. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Halaban R; Cheng E; Zhang Y; Moellmann G; Hanlon D; Michalak M; Setaluri V; Hebert DN Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6210-5. PubMed ID: 9177196 [TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism. Halaban R; Svedine S; Cheng E; Smicun Y; Aron R; Hebert DN Proc Natl Acad Sci U S A; 2000 May; 97(11):5889-94. PubMed ID: 10823941 [TBL] [Abstract][Full Text] [Related]
3. Soluble tyrosinase is an endoplasmic reticulum (ER)-associated degradation substrate retained in the ER by calreticulin and BiP/GRP78 and not calnexin. Popescu CI; Paduraru C; Dwek RA; Petrescu SM J Biol Chem; 2005 Apr; 280(14):13833-40. PubMed ID: 15677452 [TBL] [Abstract][Full Text] [Related]
4. Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinase. Svedine S; Wang T; Halaban R; Hebert DN J Cell Sci; 2004 Jun; 117(Pt 14):2937-49. PubMed ID: 15161941 [TBL] [Abstract][Full Text] [Related]
5. Tyrosinase maturation and oligomerization in the endoplasmic reticulum require a melanocyte-specific factor. Francis E; Wang N; Parag H; Halaban R; Hebert DN J Biol Chem; 2003 Jul; 278(28):25607-17. PubMed ID: 12724309 [TBL] [Abstract][Full Text] [Related]
6. DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression. Fürst K; Steder M; Logotheti S; Angerilli A; Spitschak A; Marquardt S; Schumacher T; Engelmann D; Herchenröder O; Rupp RAW; Pützer BM Cancer Lett; 2019 Feb; 442():299-309. PubMed ID: 30445206 [TBL] [Abstract][Full Text] [Related]
7. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins. Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241 [TBL] [Abstract][Full Text] [Related]
8. Cellular localization of tyrosinase in human malignant melanoma cell lines. Foa C; Aubert C J Invest Dermatol; 1977 Jun; 68(6):369-78. PubMed ID: 405430 [TBL] [Abstract][Full Text] [Related]
9. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation. Toyofuku K; Wada I; Spritz RA; Hearing VJ Biochem J; 2001 Apr; 355(Pt 2):259-69. PubMed ID: 11284711 [TBL] [Abstract][Full Text] [Related]
10. Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligands. Le Gros G; Zhang XM; Parsons PG Melanoma Res; 1994 Dec; 4(6):359-64. PubMed ID: 7535606 [TBL] [Abstract][Full Text] [Related]
11. Oligosaccharide trimming plays a role in the endoplasmic reticulum-associated degradation of tyrosinase. Wang Y; Androlewicz MJ Biochem Biophys Res Commun; 2000 Apr; 271(1):22-7. PubMed ID: 10777675 [TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas. Imokawa G; Mishima Y Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849 [TBL] [Abstract][Full Text] [Related]
14. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity. Watabe H; Valencia JC; Yasumoto K; Kushimoto T; Ando H; Muller J; Vieira WD; Mizoguchi M; Appella E; Hearing VJ J Biol Chem; 2004 Feb; 279(9):7971-81. PubMed ID: 14634018 [TBL] [Abstract][Full Text] [Related]
15. The inhibition of early N-glycan processing targets TRP-2 to degradation in B16 melanoma cells. Negroiu G; Dwek RA; Petrescu SM J Biol Chem; 2003 Jul; 278(29):27035-42. PubMed ID: 12719423 [TBL] [Abstract][Full Text] [Related]
16. [Impact on tyrosinase expression and export from endoplasmic reticulum by inhibition of 26S proteasome]. Xu W; Lin FQ; Liu JF; Fu LF; Hong WS; Zhou MN; Xu AE; Guan CP Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):123-7. PubMed ID: 23648349 [TBL] [Abstract][Full Text] [Related]
17. Isolation and biochemical characterization of tyrosinase-rich GERL and coated vesicle in melanin synthesizing cells. Imokawa G; Mishima Y Br J Dermatol; 1981 Feb; 104(2):169-78. PubMed ID: 6783060 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the cytosolic and melanosome-bound tyrosinase activities in Harding-Passey mouse melanoma. García-Borrón JC; Martinez JH; Arocas A; Solano F; Vicente V; Gómez S; Iborra JL; Lozano JA Int J Biochem; 1985; 17(9):995-1002. PubMed ID: 3934011 [TBL] [Abstract][Full Text] [Related]
19. Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine. Halaban R; Cheng E; Svedine S; Aron R; Hebert DN J Biol Chem; 2001 Apr; 276(15):11933-8. PubMed ID: 11124258 [TBL] [Abstract][Full Text] [Related]
20. Promotion of tyrosinase folding in COS 7 cells by calnexin. Toyofuku K; Wada I; Hirosaki K; Park JS; Hori Y; Jimbow K J Biochem; 1999 Jan; 125(1):82-9. PubMed ID: 9880801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]